BMO Capital Markets Reiterates Hold Rating for Healthcare Realty Trust (NYSE:HR)

Healthcare Realty Trust (NYSE:HR)‘s stock had its “hold” rating reiterated by BMO Capital Markets in a note issued to investors on Thursday, AnalystRatings.com reports. They presently have a $35.00 price objective on the real estate investment trust’s stock. BMO Capital Markets’ target price would indicate a potential downside of 4.71% from the stock’s previous close.

A number of other equities research analysts have also issued reports on HR. Mizuho restated a “neutral” rating and issued a $34.00 target price on shares of Healthcare Realty Trust in a research note on Friday, December 20th. Citigroup upgraded shares of Healthcare Realty Trust from a “neutral” rating to a “buy” rating and upped their target price for the company from $34.00 to $38.00 in a research note on Thursday, December 12th. Stifel Nicolaus upgraded shares of Healthcare Realty Trust from a “hold” rating to a “buy” rating and upped their target price for the company from $33.00 to $35.00 in a research note on Tuesday, November 26th. Finally, Zacks Investment Research lowered shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating in a research note on Monday, January 20th. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Healthcare Realty Trust has a consensus rating of “Hold” and an average target price of $35.00.

Shares of Healthcare Realty Trust stock opened at $36.73 on Thursday. The firm has a market cap of $4.92 billion, a PE ratio of 22.81, a price-to-earnings-growth ratio of 10.00 and a beta of 0.32. The firm’s 50-day simple moving average is $34.75 and its 200-day simple moving average is $33.50. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.16 and a current ratio of 0.16. Healthcare Realty Trust has a 1 year low of $29.63 and a 1 year high of $37.28.

Healthcare Realty Trust (NYSE:HR) last issued its earnings results on Wednesday, February 12th. The real estate investment trust reported $0.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.21). The company had revenue of $121.50 million during the quarter, compared to analyst estimates of $121.47 million. Healthcare Realty Trust had a net margin of 8.33% and a return on equity of 2.18%. The business’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.40 EPS. On average, equities analysts predict that Healthcare Realty Trust will post 1.66 earnings per share for the current year.

In related news, CEO Todd J. Meredith sold 9,707 shares of the stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $32.58, for a total transaction of $316,254.06. Following the sale, the chief executive officer now owns 471,565 shares in the company, valued at $15,363,587.70. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Todd J. Meredith sold 10,500 shares of the stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $32.42, for a total transaction of $340,410.00. Following the sale, the chief executive officer now owns 495,272 shares in the company, valued at approximately $16,056,718.24. The disclosure for this sale can be found here. In the last quarter, insiders have sold 23,707 shares of company stock worth $769,539. 1.87% of the stock is owned by company insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Van ECK Associates Corp bought a new position in Healthcare Realty Trust in the 4th quarter worth about $26,000. Marshall Wace North America L.P. bought a new position in Healthcare Realty Trust in the 1st quarter worth about $39,000. DekaBank Deutsche Girozentrale bought a new position in Healthcare Realty Trust in the 4th quarter worth about $103,000. NumerixS Investment Technologies Inc grew its position in Healthcare Realty Trust by 277.8% in the 4th quarter. NumerixS Investment Technologies Inc now owns 3,400 shares of the real estate investment trust’s stock worth $113,000 after purchasing an additional 2,500 shares during the last quarter. Finally, First Interstate Bank bought a new position in shares of Healthcare Realty Trust in the third quarter valued at approximately $116,000. Hedge funds and other institutional investors own 93.20% of the company’s stock.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of December 31, 2018, the Company owned 199 real estate properties in 27 states totaling 14.8 million square feet and was valued at approximately $4.9 billion.

Further Reading: What is the Shanghai Stock Exchange Composite Index?

Analyst Recommendations for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.